HOME >> MEDICINE >> NEWS
Cancer drug is first to alleviate devastating scleroderma symptoms

BACKGROUND:
Scleroderma is a debilitating autoimmune disease that attacks the connective tissues and especially the lungs. Hardening of the skin is one of the most visible effects of the disease. Over 40 percent of patients will develop symptomatic lung problems the leading cause of death for scleroderma patients.

FINDINGS:
A new nationwide study headed by UCLA found that a drug used for cancer called cyclophosphamide, helped alleviate the serious effects of scleroderma on breathing, lung function, quality of life, functional disability and skin thickness. This is the first controlled clinical trial to show a positive treatment for scleroderma lung disease.

IMPACT:
Findings will help researchers develop new drug therapies and also better understand development of the disease. The next step is further research into use of cylophosphamide as well as other immunosuppressant drugs.

AUTHORS:
Drs. Donald Tashkin and Michael Roth, professors of pulmonary and critical care medicine; and Drs. Philip Clements and Daniel Furst, professors of rheumatology, David Geffen School of Medicine at UCLA.


'"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-2270
University of California - Los Angeles
21-Jun-2006


Page: 1

Related medicine news :

1. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
2. Cancer research summaries
3. Cancer on the agenda of the Portuguese EU Council Presidency
4. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
5. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
6. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
7. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
8. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
9. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
10. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research
11. Cancer-fighting foods, supplements explored in day-long symposium, March 25

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cancer drug first alleviate devastating scleroderma symptoms

(Date:11/21/2014)... (PRWEB) November 21, 2014 In summer, ... In winter, people rarely perspire and rarely feel thirsty. ... to drink the eight glasses of fresh water a ... warns fresh water advocate Sharon Kleyne. Winter weather is ... hydration is just as important.     , ...
(Date:11/21/2014)... DressVe.com , a renowned women’s dress wholesaler and retailer ... fashion accessories. Furthermore, the company has launched its Special Black ... all its fashion items. Also, orders above $59 are qualified ... company, their wedding dresses and prom dresses are very popular ... rates. , The CEO says “We are glad to ...
(Date:11/21/2014)... OR (PRWEB) November 21, 2014 Even with ... always something to learn and room for growth, participating in ... returned from State Farm’s National Convention, a networking event with ... around the country, bringing back the latest and greatest in ... may have spotted Kirk and his team (Stacy, Anthony, Reina ...
(Date:11/21/2014)... RankingBySEO has announced an online reputation ... of lawyers, and the company has named the service ... for lawyers since it receives queries from lawyers regarding ... numbers. So far, the company has successfully repaired the ... different parts of the world, and now, it has ...
(Date:11/21/2014)... 21, 2014 Nature’s Sleep is excited to announce ... The contest calls for the creation of any type of art ... that encompasses sleep, a bed or a mattress. , “We ... Hirschhorn, Vice President of Marketing for Nature’s Sleep, “that we decided ... more than 10,000 creative entries from some very talented artists all ...
Breaking Medicine News(10 mins):Health News:Our Bodies Need Eight Glasses of Water a Day Even in Winter Reports Fresh Water Advocate 2Health News:Our Bodies Need Eight Glasses of Water a Day Even in Winter Reports Fresh Water Advocate 3Health News:DressVe.com Announces Its 2014 Special Friday Sales 2Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2Health News:RankingBySEO Announces Lawyer Reputation Management Service 2Health News:Nature’s Sleep Kicks Off their 2nd Art Of Sleep Contest 2
(Date:11/21/2014)... --  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... present at the Biotech Showcase™ 2015 taking place in ... 12-14, 2015. Michael Mullan , ... will present preclinical and clinical data for anatabine citrate, ... characteristics. Dr. Mullan will outline the Company,s regulatory strategy ...
(Date:11/21/2014)... CITY, Calif. , Nov. 21, 2014  Abaxis, ... company manufacturing point-of-care instruments and consumables for the medical, ... services to the veterinary and research markets in ... completion of a stock purchase agreement to acquire 100% ... United Kingdom based distribution organization. The transaction ...
(Date:11/21/2014)... MONTREAL , Nov. 21, 2014 /PRNewswire/ ... that the European Medicines Agency (EMA) has ... the company,s lead product candidate, for the ... is a rare, severely disabling genetic disease ... tissue swelling (flare-ups) and new abnormal bone ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3
Cached News: